To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Renal Impairment Subjects
Clinical trial NCT06598956 · COMPLETED
Trial details
- NCT number
- NCT06598956
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-12
- Primary completion
- 2025-03-17
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.